CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
28.67
+0.65 (2.32%)
Dec 20, 2024, 4:00 PM EST - Market closed
CG Oncology Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$63.88
Upside
+122.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $66 | Buy | Reiterates | $66 | +130.21% | Dec 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +161.60% | Dec 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +161.60% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +161.60% | Nov 12, 2024 |
| UBS | UBS | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +109.28% | Oct 24, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $65 | Strong Buy | Maintains | $65 | +126.72% | Oct 8, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $66 | Buy | Initiates | $66 | +130.21% | Sep 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +161.60% | Sep 17, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +126.72% | Aug 27, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +126.72% | Jun 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +161.60% | May 28, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $43 → $50 | Hold → Strong Buy | Upgrades | $43 → $50 | +74.40% | May 14, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +74.40% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +161.60% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +161.60% | May 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $75 | Buy | Reiterates | $75 | +161.60% | May 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.